510(k) Report

510(k) · Cleared

Cleared

MBT Compass HT CA Software; MBT FAST Shuttle US IVD

K251495510(k) TraditionalCleared Aug 13, 202590-day reviewClass II21 CFR 866.3378

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Bruker Daltonics GmbH & Co. KG · QBN Mass Spectrometry, Maldi Tof, Microorganism Identification, Cultured Isolates

Cleared on Aug 13, 2025 as substantially equivalent to K193419 (Bruker Daltonik GmbH, 2020) after a 90-day review. Its family tree reaches back 1 generation to 2020.

Decided
Aug 13, 2025
Review
90 days
Class
Class II
Product code
QBN
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K193419 (2020). No later device cites it as a predicate yet.

K193419 · MBT Sepsityper · Bruker Daltonik GmbH · 20202020202220242026
K193419 · MBT Sepsityper · Bruker Daltonik GmbH · 20200
  1. Root · 1 generation backK193419 MBT SepsityperBruker Daltonik GmbH · 2020
  2. This deviceK251495 MBT Compass HT CA Software; MBT FAST Shuttle US IVDBruker Daltonics GmbH & Co. KG · 2025
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K193419MBT SepsityperBruker Daltonik GmbH2020—
0 (this device)K251495MBT Compass HT CA Software; MBT FAST Shuttle US IVDBruker Daltonics GmbH & Co. KG2025—
FIG. 1 — Lineage of K251495, 2020–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QBN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QBN device

  1. #1 K212461 Vitek MS Primescore 3.3 · 2 generations · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K193419MBT Sepsityper
Summary page 5
…ed code: QNJ III. PREDICATE DEVICE Trade/Device Name: MBT-CA System with MBT Sepsityper 510(k) Submitter/Holder: Bruker Daltonics GmbH & Co. KG 510(k) Reference: K193419 IV. DEVICE DESCRIPTION The MALDI Biotyper CA System uses MALDI (matrix-assisted laser desorption/ionization) TOF (time o…
Bruker Daltonik GmbH2020—

Also cleared against K193419: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • 1 other device also cites its predicate K193419.

How does its category compare?

All QBN devices

QBN Mass Spectrometry, Maldi Tof, Microorganism Identification, Cultured Isolates: FDA decisions, review times, recalls and adverse event reports over 20 years. 2025, this device’s year, is highlighted.

FDA decisions per year · QBN

1in 2025

2018: 22022: 12025: 1
2007high 2 (2018) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QBN

Too few QBN 510(k)s in any year since 2007 to give a median.

Recalls per year · QBN

No recall names QBN since 2007.

Adverse event reports per year · QBN

2in 2025

2020: 542021: 1632022: 1352023: 392024: 172025: 2
2007high 163 (2021) · low 0 (2007)2025

MAUDE reports naming product code QBN, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20182—00
20190—00
20200—054
20210—0163
20221—0135
20230—039
20240—017
20251—02
20260—0—

What is it indicated for?

The MBT Sepsityper is a qualitative in vitro diagnostic device consisting of an MBT-CA (Sepsityper) software extension and a reagent kit (MBT Sepsityper Kit US IVD) for use in conjunction with other clinical and laboratory findings to aid in the early diagnosis of bacterial and yeast infections from positively flagged blood cultures using the MALDI Biotyper CA System. The MBT Sepsityper Kit US IVD is a disposable blood culture processing device that…

Read the full statement (266 words)

The MBT Sepsityper is a qualitative in vitro diagnostic device consisting of an MBT-CA (Sepsityper) software extension and a reagent kit (MBT Sepsityper Kit US IVD) for use in conjunction with other clinical and laboratory findings to aid in the early diagnosis of bacterial and yeast infections from positively flagged blood cultures using the MALDI Biotyper CA System.

The MBT Sepsityper Kit US IVD is a disposable blood culture processing device that includes associated reagents that are intended to concentrate and purify microbial cells from blood culture samples identified as positive by a continuous monitoring blood culture system and confirmed to demonstrate the presence of a single organism as determined by Gram stain. This sample preparation manual method is performed by laboratory health professionals in a clinical diagnostic setting. Subculturing of positive blood cultures is necessary to recover organisms for identification of organisms not identified by the MBT-CA System, for susceptibility testing and for differentiation of mixed growth.

Positive MBT Sepsityper results do not rule out co-infection with organisms that may not be detected by the MBT-CA System. Results of the MBT Sepsityper should not be used as the sole basis for diagnosis, treatment, or other patient management decisions. Results of the MBT Sepsityper should be correlated with Gram stain results and used in conjunction with other clinical and laboratory findings to aid in the diagnosis of bacterial and yeast bloodstream infections.

Organisms recovered from positive blood culture bottles that are suitable for identification using the MBT Sepsityper Kit US IVD and MBT-CA Systems are listed in the MALDI Biotyper CA System Package Insert Reference Library.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K251495: MBT Compass HT CA Software; MBT FAST Shuttle US IVD.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K251495

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026